Serum IL-17, IL-23, and TGF-β Levels in Type 1 and Type 2 Diabetic Patients and Age-Matched Healthy Controls

Type 1 diabetes is recognized as an autoimmune inflammatory disease and low grade inflammation is also observed in type 2 diabetic patients. Interleukin 17 (IL-17) is a new player in inflammation. Th17 cells, as the main source of IL-17, require transforming growth factor β (TGF-β) and interleukin 2...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Roohi, Azam, Tabrizi, Mina, Abbasi, Farzaneh, Ataie-Jafari, Asal, Nikbin, Behrouz, Larijani, Bagher, Qorbani, Mostafa, Meysamie, Alipasha, Asgarian-Omran, Hossein, Nikmanesh, Bahram, Bajouri, Arezou, Shafiey, Novin, Maleki, Akram
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi Publishing Corporation 2014
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4065742/
https://ncbi.nlm.nih.gov/pubmed/24995325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/718946
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller